
Peptide
PT-141
Also referred to as Bremelanotide, Vyleesi
A melanocortin receptor agonist with genuine phase 3 evidence, approved in the United States but not in the UK.
Studied in
- Melanocortin signalling
- Sexual medicine research
Fields in which this material has been studied. This is not a statement that it is effective for anything.
Prices
Vials
10 mg
P41
In stock£19.99
Prices are per unit and exclude delivery. Supplied for laboratory research use only. Open a trade account for volume terms.
Questions about specification or documentation? Get in touch.